Diabetes and cancer (2): Evaluating the impact of diabetes on mortality In patients with cancer

Diabetologia

Volumn 55, Issue 6, 2012, Pages 1619-1632

  Renehan, A G ^a   Yeh, H C ^b   Johnson, J A ^c   Wild, S H ^d   Gale, E A M ^e   Moller H ^f  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Bias; Cancer; Confounding; Diabetes; Epidemiology; Review; Type 2 diabetes

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; HORMONE; LEVAMISOLE; METFORMIN;

BLADDER CANCER; BRACHYTHERAPY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER STAGING; CANCER SURGERY; CHEMOTHERAPY INDUCED EMESIS; COHORT ANALYSIS; COLON CANCER; COLORECTAL CANCER; DIARRHEA; DRUG FEVER; ENDOMETRIUM CANCER; HUMAN; INFECTION; KIDNEY CANCER; LEUKOPENIA; LIVER CANCER; LIVER CELL CARCINOMA; LUNG CANCER; MALIGNANT NEOPLASTIC DISEASE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; PANCREAS CANCER; PRIORITY JOURNAL; PROSTATE CANCER; RECTUM CANCER; REVIEW; STOMATITIS; UTERINE CERVIX CANCER; MORTALITY; NEOPLASM; RISK FACTOR;

DIABETES MELLITUS, TYPE 2; HUMANS; NEOPLASMS; RISK FACTORS;

EID: 84865411135     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-012-2526-0     Document Type: Review

References (57)

1. Johnson JA, Carstensen A, Whitte D, Bowker SL, Lipscombe L (2011) Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence. Diabetologia doi:10.1007/s00125-012-2525-1
2. Buchs AE, Silverman BG (2011) Incidence of malignancies in patients with diabetes mellitus and correlation with treatment modalities in a large Israeli health maintenance organization: a historical cohort study. Metabolism 60:1379-1385
3. Snyder CF, Stein KB, Barone BB et al (2010) Does pre-existing diabetes affect prostate cancer prognosis? A systematic review. Prostate Cancer Prostatic Dis 13:58-64
4. Stein KB, Snyder CF, Barone BB et al (2010) Colorectal cancer outcomes, recurrence, and complications in persons with and without diabetes mellitus: a systematic review and meta-analysis. Dig Dis Sci 55:1839-1851
5. Peairs KS, Barone BB, Snyder CF et al (2011) Diabetes mellitus and breast cancer outcomes: a systematic review and metaanalysis. J Clin Oncol 29:40-46
6. van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986-1992 (Pubitemid 46418378)
7. Beckman TJ, Cuddihy RM, Scheitel SM, Naessens JM, Killian JM, Pankratz VS (2001) Screening mammogram utilization in women with diabetes. Diabetes Care 24:2049-2053 (Pubitemid 33716519)
8. Fontana SA, Baumann LC, Helberg C, Love RR (1997) The delivery of preventive services in primary care practices according to chronic disease status. Am J Public Health 87:1190-1196
9. McBean AM, Yu X (2007) The underuse of screening services among elderly women with diabetes. Diabetes Care 30:1466-1472 (Pubitemid 46871156)
10. Lipscombe LL, Hux JE, Booth GL (2005) Reduced screening mammography among women with diabetes. Arch Intern Med 165:2090-2095 (Pubitemid 41434583)
11. Zhao G, Ford ES, Ahluwalia IB, Li C, Mokdad AH (2009) Prevalence and trends of receipt of cancer screenings among US women with diagnosed diabetes. J Gen Intern Med 24:270-275
12. Jimenez-Garcia R, Hernandez-Barrera V, Carrasco-Garrido P, Gil A (2009) Prevalence and predictors of breast and cervical cancer screening among Spanish women with diabetes. Diabetes Care 32:1470-1472
13. Banks E, Beral V, Cameron R et al (2002) Comparison of various characteristics of women who do and do not attend for breast cancer screening. Breast Cancer Res 4:R1 (Pubitemid 34097556)
14. Sellers TA, Jensen LE, Vierkant RA et al (2007) Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study. Cancer Causes Control 18:505-515 (Pubitemid 46684825)
15. Marshall JG, Cowell JM, Campbell ES, McNaughton DB (2010) Regional variations in cancer screening rates found in women with diabetes. Nurs Res 59:34-41
16. Bell RA, Shelton BJ, Paskett ED (2001) Colorectal cancer screening in North Carolina: associations with diabetes mellitus and demographic and health characteristics. Prev Med 32:163-167 (Pubitemid 34136705)
17. Heo M, Allison DB, Fontaine KR (2004) Overweight, obesity, and colorectal cancer screening: disparity between men and women. BMC Public Health 4:53
18. Fontaine KR, Heo M, Allison DB (2005) Obesity and prostate cancer screening in the USA. Public Health 119:694-698 (Pubitemid 40790499)
19. Beebe-Dimmer JL, Faerber GJ, Morgenstern H et al (2008) Body composition and serum prostate-specific antigen: review and findings from Flint Men's Health Study. Urology 71:554-560
20. Grubb RL 3rd, Black A, Izmirlian G et al (2009) Serum prostatespecific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Cancer Epidemiol Biomarkers Prev 18:748-751
21. Renehan A, Tyson M, Egger M, Heller RF, Zwahlen M (2008) Body mass index and incidence of cancer: a systematic review and metaanalysis of prospective observational studies. Lancet 371:569-578 (Pubitemid 351232031)
22. Werny DM, Saraiya M, Gregg EW (2006) Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002. Am J Epidemiol 164:978-983 (Pubitemid 44729839)
23. Dhindsa S, Upadhyay M, Viswanathan P, Howard S, Chaudhuri A, Dandona P (2008) Relationship of prostate-specific antigen to age and testosterone in men with type 2 diabetes mellitus. Endocr Pract 14:1000-1005
24. Joseph DA, Thompson T, Saraiya M, Werny DM (2010) Association between glomerular filtration rate, free, total, and percent free prostate-specific antigen. Urology 76:1042-1046
25. Tabaei BP, Herman WH, Jabarin AF, Kim C (2005) Does diabetes care compete with the provision of women's preventive care services? Diabetes Care 28:2644-2649 (Pubitemid 43951153)
26. Fleming ST, Pursley HG, Newman B, Pavlov D, Chen K (2005) Comorbidity as a predictor of stage of illness for patients with breast cancer. Med Care 43:132-140 (Pubitemid 40222631)
27. Srokowski TP, Fang S, Hortobagyi GN, Giordano SH (2009) Impact of diabetes mellitus on complications and outcomes of adjuvant chemotherapy in older patients with breast cancer. J Clin Oncol 27:2170-2176
28. Yancik R, Wesley MN, Ries LA, Havlik RJ, Edwards BK, Yates JW (2001) Effect of age and comorbidity in postmenopausal breast cancer patients aged 55 years and older. JAMA 285:885-892 (Pubitemid 32171549)
29. Freedland SJ, Banez LL, Sun LL, Fitzsimons NJ, Moul JW (2009) Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database. Prostate Cancer Prostatic Dis 12:259-263
30. Rodriguez C, Freedland SJ, Deka A et al (2007) Body mass index, weight change, and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort. Cancer Epidemiol Biomarkers Prev 16:63-69 (Pubitemid 46174265)
31. D'Amico AV, Braccioforte MH, Moran BJ, Chen MH (2010) Causes of death in men with prevalent diabetes and newly diagnosed high-versus favorable-risk prostate cancer. Int J Radiat Oncol Biol Phys 77:1329-1337
32. Chan JM, Latini DM, Cowan J, Duchane J, Carroll PR (2005) History of diabetes, clinical features of prostate cancer, and prostate cancer recurrence-data from CaPSURE (United States). Cancer Causes Control 16:789-797 (Pubitemid 41160043)
33. Little SA, Jarnagin WR, DeMatteo RP, Blumgart LH, Fong Y (2002) Diabetes is associated with increased perioperative mortality but equivalent long-term outcome after hepatic resection for colorectal cancer. J Gastrointest Surg 6:88-94 (Pubitemid 40433594)
34. Meyerhardt JA, Catalano PJ, Haller DG et al (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21:433-440 (Pubitemid 46606471)
35. Gross CP, McAvay GJ, Guo Z, Tinetti ME (2007) The impact of chronic illnesses on the use and effectiveness of adjuvant chemotherapy for colon cancer. Cancer 109:2410-2419 (Pubitemid 46906459)
36. Davila JA, Rabeneck L, Berger DH, El-Serag HB (2005) Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction. Dig Dis Sci 50:1722-1728 (Pubitemid 41203672)
37. Herold DM, Hanlon AL, Hanks GE (1999) Diabetes mellitus: a predictor for late radiation morbidity. Int J Radiat Oncol Biol Phys 43:475-479 (Pubitemid 29107163)
38. Barone BB, Yeh HC, Snyder CF et al (2010) Postoperative mortality in cancer patients with preexisting diabetes: systematic review and meta-analysis. Diabetes Care 33:931-939
39. Wilt TJ, Cowper DC, Gammack JK, Going DR, Nugent S, Borowsky SJ (1999) An evaluation of radical prostatectomy at Veterans Affairs Medical Centers: time trends and geographic variation in utilization and outcomes. Med Care 37:1046-1056
40. Siddiqui AA, Spechler SJ, Huerta S, Dredar S, Little BB, Cryer B (2008) Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci 53:2486-2494
41. Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 30:466-472 (Pubitemid 44750406)
42. Payne JE, Meyer HJ (1995) The influence of other diseases upon the outcome of colorectal cancer patients. Aust N Z J Surg 65:398-402
43. Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147:816-825 (Pubitemid 28244386)
44. Hammarsten J, Hogstedt B (2005) Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41:2887-2895 (Pubitemid 41713128)
45. Merrick GS, Galbreath RW, Butler WM et al (2007) Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer. Cancer 110:289-296 (Pubitemid 47121888)
46. Smith MR, Bae K, Efstathiou JA et al (2008) Diabetes and mortality in men with locally advanced prostate cancer: RTOG 92-02. J Clin Oncol 26:4333-4339
47. Froehner M, Koch R, Litz R et al (2003) Preoperative cardiopulmonary risk assessment as predictor of early noncancer and overall mortality after radical prostatectomy. Urology 61:596-600 (Pubitemid 36294198)
48. Keating NL, Zaslavsky AM, Herrinton LJ, Selby JV, Wolf RE, Ayanian JZ (2007) Quality of diabetes care among cancer survivors with diabetes. Med Care 45:869-875
49. Chiao EY, Nambi PV, Naik AD (2010) The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv 4:381-387
50. Hanchate AD, Clough-Gorr KM, Ash AS, Thwin SS, Silliman RA (2010) Longitudinal patterns in survival, comorbidity, healthcare utilization and quality of care among older women following breast cancer diagnosis. J Gen Intern Med 25:1045-1050
51. Jiralerspong S, Palla SL, Giordano SH et al (2009) Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer. J Clin Oncol 27:3297-3302
52. Lee JH, Kim TI, Jeon SM, Hong SP, Cheon JH, Kim WH (2011) The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus. Int J Cancer. doi:10.1002/ijc.26421
53. Tan BX, Yao WX, Ge J et al (2011) Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes. Cancer 117:5103-5111
54. Bokhman JV (1983) Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 15:10-17 (Pubitemid 13194678)
55. Suzuki R, Orsini N, Saji S, Key TJ, Wolk A (2009) Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status-a meta-analysis. Int J Cancer 124:698-712
56. Yang XR, Chang-Claude J, Goode EL et al (2011) Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the breast cancer association consortium studies. J Natl Cancer Inst 103:250-263
57. Campbell PT, Jacobs ET, Ulrich CM et al (2010) Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 102:391-400